In patients with germline RUNX1 mutations, a second allele often acquires somatic mutation at the time of progression to an overt myeloid neoplasm, likely as a result of an impaired DNA repair pathway and an increased mutagenicity. The gene discussed is RUNX1; the disease is myeloid neoplasm.